Found 138 with Last Name = 'hachiya' and Initial = 's' 
Affinity DataKi: 20nMAssay Description:Inhibition of human factor 10A using chromogenic substrate S2222 by dixon plot analysisMore data for this Ligand-Target Pair
Affinity DataKi: 31nMAssay Description:Inhibition of human factor 10A using chromogenic substrate S2222 by dixon plot analysisMore data for this Ligand-Target Pair
Affinity DataKi: 1.10E+4nMAssay Description:Inhibition of human plasma kallikrein using chromogenic substrate S2302 by dixon plot analysisMore data for this Ligand-Target Pair
Affinity DataKi: 1.70E+4nMAssay Description:Inhibition of human plasma kallikrein using chromogenic substrate S2302 by dixon plot analysisMore data for this Ligand-Target Pair
Affinity DataKi: >1.00E+5nMAssay Description:Inhibition of human thrombin using chromogenic substrate S2238 by dixon plot analysisMore data for this Ligand-Target Pair
Affinity DataKi: >1.00E+5nMAssay Description:Inhibition of human thrombin using chromogenic substrate S2238 by dixon plot analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 28.6nMAssay Description:Inhibition of human factor 10A using chromogenic substrate S2222 by fluorometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 31.1nMAssay Description:Inhibition of human factor 10A using chromogenic substrate S2222 by fluorometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 41.3nMAssay Description:Inhibition of human factor 10A using chromogenic substrate S2222 by fluorometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 41.4nMAssay Description:Inhibition of human factor 10A using chromogenic substrate S2222 by fluorometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 50.3nMAssay Description:Inhibition of human factor 10A using chromogenic substrate S2222 by fluorometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 54.6nMAssay Description:Inhibition of human factor 10A using chromogenic substrate S2222 by fluorometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 59.8nMAssay Description:Inhibition of human factor 10A using chromogenic substrate S2222 by fluorometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 62.6nMAssay Description:Inhibition of human factor 10A using chromogenic substrate S2222 by fluorometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 64.2nMAssay Description:Inhibition of human factor 10A using chromogenic substrate S2222 by fluorometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 73.4nMAssay Description:Inhibition of human factor 10A using chromogenic substrate S2222 by fluorometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 86.1nMAssay Description:Inhibition of human factor 10A using chromogenic substrate S2222 by fluorometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 99.2nMAssay Description:Inhibition of human factor 10A using chromogenic substrate S2222 by fluorometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 103nMAssay Description:Inhibition of human factor 10A using chromogenic substrate S2222 by fluorometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 106nMAssay Description:Inhibition of human factor 10A using chromogenic substrate S2222 by fluorometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 118nMAssay Description:Inhibition of human factor 10A using chromogenic substrate S2222 by fluorometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 123nMAssay Description:Inhibition of human factor 10A using chromogenic substrate S2222 by fluorometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 140nMAssay Description:Inhibition of human factor 10A using chromogenic substrate S2222 by fluorometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 155nMAssay Description:Inhibition of human factor 10A using chromogenic substrate S2222 by fluorometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 157nMAssay Description:Inhibition of human factor 10A using chromogenic substrate S2222 by fluorometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 213nMAssay Description:Inhibition of human factor 10A using chromogenic substrate S2222 by fluorometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 349nMAssay Description:Inhibition of human factor 10A using chromogenic substrate S2222 by fluorometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 539nMAssay Description:Inhibition of human factor 10A using chromogenic substrate S2222 by fluorometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 1.44E+3nMAssay Description:Inhibition of human factor 10A using chromogenic substrate S2222 by fluorometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 4.22E+3nMAssay Description:Inhibition of human factor 10A using chromogenic substrate S2222 by fluorometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 6.14E+3nMAssay Description:Inhibition of human factor 10A using chromogenic substrate S2222 by fluorometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 6.22E+3nMAssay Description:Inhibition of human factor 10A using chromogenic substrate S2222 by fluorometric analysisMore data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 5.50E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 2.60E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 720nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 1.40E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 6.40E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 1.70E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 9.60E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 5.70E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 720nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 1.30E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 780nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 840nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 4.40E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 2.80E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 2.10E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 1.60E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 3.60E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 4.00E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
